Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.

Patel, Shyam A; Longacre, Teri A; Ladabaum, Uri; Lebensohn, Alexandra; Lin, Albert Y; Haraldsdottir, Sigurdis

Patel, Shyam A; Longacre, Teri A; Ladabaum, Uri; Lebensohn, Alexandra; Lin, Albert Y; Haraldsdottir, Sigurdis.

Afiliação

Patel SA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California, USA shyam2@stanford.edu.
Longacre TA; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Ladabaum U; Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Lebensohn A; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California, USA.
Lin AY; Division of Oncology, Department of Internal Medicine, VA Palo Alto Health Care System, Palo Alto, California, USA.
Haraldsdottir S; Department of Medicine, Stanford University, Stanford, California, USA.

Oncologist ; 23(12): 1395-1400, 2018 12.

Article em En | MEDLINE | ID: mdl-30072391

Assuntos

Neoplasias Colorretais Hereditárias sem Polipose/genética; Reparo de Erro de Pareamento de DNA/genética; Receptor de Morte Celular Programada 1/antagonistas & inibidores; Feminino; Humanos; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Reparo de Erro de Pareamento de DNA / Receptor de Morte Celular Programada 1 Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google